Hussain, M B <br/><br/>
Reciprocal regulation of cGMP-mediated vasorelaxation by soluble and particulate guanylate cyclases.  [electronic resource] 

 -  American journal of physiology. Heart and circulatory physiology  Mar 2001 
 - H1151-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0363-6135 
<br/><br/><label>Standard No.: </label>10.1152/ajpheart.2001.280.3.H1151  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Aorta--physiology<br/>Atrial Natriuretic Factor--metabolism<br/>Cyclic GMP--metabolism<br/>Disease Models, Animal<br/>Dose-Response Relationship, Drug<br/>Enzyme Inhibitors--pharmacology<br/>Guanylate Cyclase--metabolism<br/>Homeostasis--physiology<br/>Humans<br/>Mammary Arteries--physiology<br/>Mice<br/>Mice, Knockout<br/>Muscle, Smooth, Vascular--enzymology<br/>Nitric Oxide--deficiency<br/>Nitric Oxide Donors--pharmacology<br/>Nitric Oxide Synthase--genetics<br/>Nitric Oxide Synthase Type II<br/>Nitric Oxide Synthase Type III<br/>Nitrogen Oxides<br/>Nitroglycerin--pharmacology<br/>Phenylephrine--pharmacology<br/>Solubility<br/>Spermine--analogs & derivatives<br/>Vasoconstriction--drug effects<br/>Vasoconstrictor Agents--pharmacology<br/>Vasodilation--drug effects<br/>Vasodilator Agents--pharmacology<br/>omega-N-Methylarginine--pharmacology